nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—Mental retardation—Capecitabine—esophageal cancer	0.0296	0.0525	CcSEcCtD
Oxymorphone—Naloxone—TLR4—esophageal cancer	0.0264	0.483	CrCbGaD
Oxymorphone—Ileus paralytic—Capecitabine—esophageal cancer	0.015	0.0265	CcSEcCtD
Oxymorphone—Altered state of consciousness—Capecitabine—esophageal cancer	0.014	0.0248	CcSEcCtD
Oxymorphone—Swelling face—Capecitabine—esophageal cancer	0.0136	0.0241	CcSEcCtD
Oxymorphone—Pneumothorax—Capecitabine—esophageal cancer	0.013	0.023	CcSEcCtD
Oxymorphone—Respiratory distress—Capecitabine—esophageal cancer	0.0102	0.018	CcSEcCtD
Oxymorphone—Ileus—Capecitabine—esophageal cancer	0.00914	0.0162	CcSEcCtD
Oxymorphone—Pain—Carboplatin—esophageal cancer	0.00913	0.0162	CcSEcCtD
Oxymorphone—Buprenorphine—CYP2A6—esophageal cancer	0.00851	0.156	CrCbGaD
Oxymorphone—Body temperature increased—Carboplatin—esophageal cancer	0.00844	0.0149	CcSEcCtD
Oxymorphone—Memory impairment—Capecitabine—esophageal cancer	0.00824	0.0146	CcSEcCtD
Oxymorphone—Lung disorder—Methotrexate—esophageal cancer	0.0068	0.0121	CcSEcCtD
Oxymorphone—Amnesia—Cisplatin—esophageal cancer	0.00678	0.012	CcSEcCtD
Oxymorphone—Injection site reaction—Capecitabine—esophageal cancer	0.00643	0.0114	CcSEcCtD
Oxymorphone—Hydromorphone—PTGS1—esophageal cancer	0.00643	0.118	CrCbGaD
Oxymorphone—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00625	0.0111	CcSEcCtD
Oxymorphone—Dehydration—Cisplatin—esophageal cancer	0.00593	0.0105	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00582	0.0103	CcSEcCtD
Oxymorphone—Apnoea—Methotrexate—esophageal cancer	0.00568	0.0101	CcSEcCtD
Oxymorphone—Mental disability—Capecitabine—esophageal cancer	0.00561	0.00994	CcSEcCtD
Oxymorphone—Sweating increased—Cisplatin—esophageal cancer	0.00536	0.0095	CcSEcCtD
Oxymorphone—Oliguria—Methotrexate—esophageal cancer	0.00523	0.00926	CcSEcCtD
Oxymorphone—Hot flush—Capecitabine—esophageal cancer	0.00502	0.00889	CcSEcCtD
Oxymorphone—Amnesia—Capecitabine—esophageal cancer	0.005	0.00885	CcSEcCtD
Oxymorphone—Menopausal symptoms—Capecitabine—esophageal cancer	0.00498	0.00882	CcSEcCtD
Oxymorphone—Lethargy—Capecitabine—esophageal cancer	0.00479	0.00849	CcSEcCtD
Oxymorphone—Diplopia—Capecitabine—esophageal cancer	0.0047	0.00832	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00465	0.00824	CcSEcCtD
Oxymorphone—Bradycardia—Cisplatin—esophageal cancer	0.00449	0.00795	CcSEcCtD
Oxymorphone—Urinary retention—Capecitabine—esophageal cancer	0.00447	0.00791	CcSEcCtD
Oxymorphone—Dehydration—Capecitabine—esophageal cancer	0.00437	0.00774	CcSEcCtD
Oxymorphone—Urinary tract disorder—Cisplatin—esophageal cancer	0.00435	0.00771	CcSEcCtD
Oxymorphone—Urethral disorder—Cisplatin—esophageal cancer	0.00432	0.00765	CcSEcCtD
Oxymorphone—Naltrexone—ABCB1—esophageal cancer	0.00431	0.0789	CrCbGaD
Oxymorphone—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00429	0.0076	CcSEcCtD
Oxymorphone—Visual impairment—Cisplatin—esophageal cancer	0.00425	0.00752	CcSEcCtD
Oxymorphone—Eye disorder—Cisplatin—esophageal cancer	0.00412	0.0073	CcSEcCtD
Oxymorphone—Flushing—Cisplatin—esophageal cancer	0.00409	0.00725	CcSEcCtD
Oxymorphone—Cardiac disorder—Cisplatin—esophageal cancer	0.00409	0.00725	CcSEcCtD
Oxymorphone—Abdominal distension—Capecitabine—esophageal cancer	0.00409	0.00724	CcSEcCtD
Oxymorphone—Bronchospasm—Capecitabine—esophageal cancer	0.00399	0.00707	CcSEcCtD
Oxymorphone—Immune system disorder—Cisplatin—esophageal cancer	0.00398	0.00705	CcSEcCtD
Oxymorphone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00397	0.00704	CcSEcCtD
Oxymorphone—Sweating increased—Capecitabine—esophageal cancer	0.00395	0.007	CcSEcCtD
Oxymorphone—Malnutrition—Cisplatin—esophageal cancer	0.00384	0.0068	CcSEcCtD
Oxymorphone—Flatulence—Cisplatin—esophageal cancer	0.00378	0.0067	CcSEcCtD
Oxymorphone—Visual disturbance—Methotrexate—esophageal cancer	0.00369	0.00654	CcSEcCtD
Oxymorphone—Weight decreased—Capecitabine—esophageal cancer	0.00367	0.0065	CcSEcCtD
Oxymorphone—Pneumonia—Capecitabine—esophageal cancer	0.00364	0.00645	CcSEcCtD
Oxymorphone—Vision blurred—Cisplatin—esophageal cancer	0.00362	0.00641	CcSEcCtD
Oxymorphone—Lethargy—Methotrexate—esophageal cancer	0.00357	0.00632	CcSEcCtD
Oxymorphone—Convulsion—Cisplatin—esophageal cancer	0.00332	0.00589	CcSEcCtD
Oxymorphone—Bradycardia—Capecitabine—esophageal cancer	0.00331	0.00586	CcSEcCtD
Oxymorphone—Anxiety—Cisplatin—esophageal cancer	0.00326	0.00577	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00324	0.00575	CcSEcCtD
Oxymorphone—Urinary tract disorder—Capecitabine—esophageal cancer	0.00321	0.00568	CcSEcCtD
Oxymorphone—Urethral disorder—Capecitabine—esophageal cancer	0.00318	0.00564	CcSEcCtD
Oxymorphone—Buprenorphine—ABCB1—esophageal cancer	0.00317	0.058	CrCbGaD
Oxymorphone—Naloxone—ABCB1—esophageal cancer	0.00315	0.0576	CrCbGaD
Oxymorphone—Oedema—Cisplatin—esophageal cancer	0.00313	0.00555	CcSEcCtD
Oxymorphone—Visual impairment—Capecitabine—esophageal cancer	0.00313	0.00555	CcSEcCtD
Oxymorphone—Nervous system disorder—Cisplatin—esophageal cancer	0.00307	0.00544	CcSEcCtD
Oxymorphone—Tachycardia—Cisplatin—esophageal cancer	0.00306	0.00541	CcSEcCtD
Oxymorphone—Skin disorder—Cisplatin—esophageal cancer	0.00304	0.00539	CcSEcCtD
Oxymorphone—Eye disorder—Capecitabine—esophageal cancer	0.00304	0.00538	CcSEcCtD
Oxymorphone—Hyperhidrosis—Cisplatin—esophageal cancer	0.00303	0.00536	CcSEcCtD
Oxymorphone—Flushing—Capecitabine—esophageal cancer	0.00302	0.00534	CcSEcCtD
Oxymorphone—Cardiac disorder—Capecitabine—esophageal cancer	0.00302	0.00534	CcSEcCtD
Oxymorphone—Anorexia—Cisplatin—esophageal cancer	0.00298	0.00529	CcSEcCtD
Oxymorphone—Angiopathy—Capecitabine—esophageal cancer	0.00295	0.00522	CcSEcCtD
Oxymorphone—Immune system disorder—Capecitabine—esophageal cancer	0.00293	0.0052	CcSEcCtD
Oxymorphone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00293	0.00519	CcSEcCtD
Oxymorphone—Hypotension—Cisplatin—esophageal cancer	0.00293	0.00518	CcSEcCtD
Oxymorphone—Mental disorder—Capecitabine—esophageal cancer	0.00285	0.00504	CcSEcCtD
Oxymorphone—Malnutrition—Capecitabine—esophageal cancer	0.00283	0.00501	CcSEcCtD
Oxymorphone—Dyspnoea—Cisplatin—esophageal cancer	0.00279	0.00495	CcSEcCtD
Oxymorphone—Flatulence—Capecitabine—esophageal cancer	0.00279	0.00494	CcSEcCtD
Oxymorphone—Decreased appetite—Cisplatin—esophageal cancer	0.00272	0.00482	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—esophageal cancer	0.00271	0.0048	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0027	0.00479	CcSEcCtD
Oxymorphone—Pain—Cisplatin—esophageal cancer	0.00268	0.00474	CcSEcCtD
Oxymorphone—Vision blurred—Capecitabine—esophageal cancer	0.00267	0.00472	CcSEcCtD
Oxymorphone—Morphine—ABCB1—esophageal cancer	0.00266	0.0486	CrCbGaD
Oxymorphone—Feeling abnormal—Cisplatin—esophageal cancer	0.00258	0.00457	CcSEcCtD
Oxymorphone—Vertigo—Capecitabine—esophageal cancer	0.00254	0.0045	CcSEcCtD
Oxymorphone—Syncope—Capecitabine—esophageal cancer	0.00254	0.00449	CcSEcCtD
Oxymorphone—Palpitations—Capecitabine—esophageal cancer	0.0025	0.00443	CcSEcCtD
Oxymorphone—Loss of consciousness—Capecitabine—esophageal cancer	0.00249	0.0044	CcSEcCtD
Oxymorphone—Body temperature increased—Cisplatin—esophageal cancer	0.00248	0.00438	CcSEcCtD
Oxymorphone—Hypertension—Capecitabine—esophageal cancer	0.00244	0.00433	CcSEcCtD
Oxymorphone—Chest pain—Capecitabine—esophageal cancer	0.00241	0.00427	CcSEcCtD
Oxymorphone—Anxiety—Capecitabine—esophageal cancer	0.0024	0.00425	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00239	0.00424	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—esophageal cancer	0.00239	0.00423	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—esophageal cancer	0.00237	0.0042	CcSEcCtD
Oxymorphone—Dry mouth—Capecitabine—esophageal cancer	0.00235	0.00417	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—esophageal cancer	0.00233	0.00413	CcSEcCtD
Oxymorphone—Confusional state—Capecitabine—esophageal cancer	0.00233	0.00412	CcSEcCtD
Oxymorphone—Oedema—Capecitabine—esophageal cancer	0.00231	0.00409	CcSEcCtD
Oxymorphone—Hypersensitivity—Cisplatin—esophageal cancer	0.00231	0.00409	CcSEcCtD
Oxymorphone—Shock—Capecitabine—esophageal cancer	0.00227	0.00402	CcSEcCtD
Oxymorphone—Nervous system disorder—Capecitabine—esophageal cancer	0.00226	0.00401	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—esophageal cancer	0.00226	0.004	CcSEcCtD
Oxymorphone—Tachycardia—Capecitabine—esophageal cancer	0.00225	0.00399	CcSEcCtD
Oxymorphone—Asthenia—Cisplatin—esophageal cancer	0.00225	0.00398	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—esophageal cancer	0.00224	0.00398	CcSEcCtD
Oxymorphone—Skin disorder—Capecitabine—esophageal cancer	0.00224	0.00397	CcSEcCtD
Oxymorphone—Hyperhidrosis—Capecitabine—esophageal cancer	0.00223	0.00395	CcSEcCtD
Oxymorphone—Anorexia—Capecitabine—esophageal cancer	0.0022	0.0039	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—esophageal cancer	0.00219	0.00389	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—esophageal cancer	0.00218	0.00387	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—esophageal cancer	0.00218	0.00386	CcSEcCtD
Oxymorphone—Hypotension—Capecitabine—esophageal cancer	0.00216	0.00382	CcSEcCtD
Oxymorphone—Diarrhoea—Cisplatin—esophageal cancer	0.00214	0.0038	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—esophageal cancer	0.00212	0.00375	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—esophageal cancer	0.00211	0.00373	CcSEcCtD
Oxymorphone—Insomnia—Capecitabine—esophageal cancer	0.00209	0.0037	CcSEcCtD
Oxymorphone—Dyspnoea—Capecitabine—esophageal cancer	0.00206	0.00365	CcSEcCtD
Oxymorphone—Dyspepsia—Capecitabine—esophageal cancer	0.00203	0.0036	CcSEcCtD
Oxymorphone—Decreased appetite—Capecitabine—esophageal cancer	0.00201	0.00355	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00199	0.00353	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—esophageal cancer	0.00199	0.00353	CcSEcCtD
Oxymorphone—Fatigue—Capecitabine—esophageal cancer	0.00199	0.00353	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—esophageal cancer	0.00198	0.00351	CcSEcCtD
Oxymorphone—Pain—Capecitabine—esophageal cancer	0.00197	0.0035	CcSEcCtD
Oxymorphone—Constipation—Capecitabine—esophageal cancer	0.00197	0.0035	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—esophageal cancer	0.00197	0.00349	CcSEcCtD
Oxymorphone—Feeling abnormal—Capecitabine—esophageal cancer	0.0019	0.00337	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—esophageal cancer	0.00189	0.00335	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00189	0.00334	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—esophageal cancer	0.00186	0.00329	CcSEcCtD
Oxymorphone—Urticaria—Capecitabine—esophageal cancer	0.00183	0.00325	CcSEcCtD
Oxymorphone—Abdominal pain—Capecitabine—esophageal cancer	0.00182	0.00323	CcSEcCtD
Oxymorphone—Body temperature increased—Capecitabine—esophageal cancer	0.00182	0.00323	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—esophageal cancer	0.00182	0.00323	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—esophageal cancer	0.00179	0.00318	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00178	0.00315	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—esophageal cancer	0.00173	0.00307	CcSEcCtD
Oxymorphone—Hypersensitivity—Capecitabine—esophageal cancer	0.0017	0.00301	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—esophageal cancer	0.00169	0.00298	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—esophageal cancer	0.00167	0.00296	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00166	0.00294	CcSEcCtD
Oxymorphone—Asthenia—Capecitabine—esophageal cancer	0.00166	0.00293	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—esophageal cancer	0.00164	0.0029	CcSEcCtD
Oxymorphone—Pruritus—Capecitabine—esophageal cancer	0.00163	0.00289	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—esophageal cancer	0.00161	0.00284	CcSEcCtD
Oxymorphone—Diarrhoea—Capecitabine—esophageal cancer	0.00158	0.0028	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—esophageal cancer	0.00155	0.00275	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—esophageal cancer	0.00153	0.00271	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—esophageal cancer	0.00153	0.00271	CcSEcCtD
Oxymorphone—Dizziness—Capecitabine—esophageal cancer	0.00153	0.0027	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—esophageal cancer	0.00151	0.00268	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—esophageal cancer	0.00149	0.00265	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00148	0.00263	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—esophageal cancer	0.00148	0.00262	CcSEcCtD
Oxymorphone—Pain—Methotrexate—esophageal cancer	0.00147	0.0026	CcSEcCtD
Oxymorphone—Vomiting—Capecitabine—esophageal cancer	0.00147	0.0026	CcSEcCtD
Oxymorphone—Dermatitis—Capecitabine—esophageal cancer	0.00145	0.00258	CcSEcCtD
Oxymorphone—Headache—Capecitabine—esophageal cancer	0.00145	0.00256	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—esophageal cancer	0.00142	0.00251	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00141	0.00249	CcSEcCtD
Oxymorphone—Nausea—Capecitabine—esophageal cancer	0.00137	0.00243	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—esophageal cancer	0.00137	0.00242	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—esophageal cancer	0.00136	0.00241	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—esophageal cancer	0.00136	0.00241	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—esophageal cancer	0.00127	0.00224	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—esophageal cancer	0.00123	0.00218	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—esophageal cancer	0.00122	0.00215	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—esophageal cancer	0.00118	0.00208	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—esophageal cancer	0.00114	0.00201	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—esophageal cancer	0.00109	0.00194	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—esophageal cancer	0.00108	0.00192	CcSEcCtD
Oxymorphone—Headache—Methotrexate—esophageal cancer	0.00108	0.00191	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—esophageal cancer	0.00102	0.00181	CcSEcCtD
Oxymorphone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000747	0.00196	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000735	0.00193	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—SST—esophageal cancer	0.00073	0.00192	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKAP13—esophageal cancer	0.00073	0.00192	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000717	0.00188	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—GHRL—esophageal cancer	0.000712	0.00187	CbGpPWpGaD
Oxymorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000706	0.00185	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000704	0.00185	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—GNG7—esophageal cancer	0.000699	0.00184	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000694	0.00182	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000685	0.0018	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000669	0.00176	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PDE4D—esophageal cancer	0.000667	0.00175	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KMT2D—esophageal cancer	0.000658	0.00173	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000646	0.0017	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000644	0.00169	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKAP13—esophageal cancer	0.00064	0.00168	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000637	0.00167	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—GNG7—esophageal cancer	0.000635	0.00167	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000616	0.00162	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—GNG7—esophageal cancer	0.000613	0.00161	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—WWOX—esophageal cancer	0.000612	0.00161	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.00061	0.0016	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000602	0.00158	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000595	0.00156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000586	0.00154	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PDE4D—esophageal cancer	0.000585	0.00154	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FKBP1A—esophageal cancer	0.000582	0.00153	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000574	0.00151	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000572	0.0015	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—WIF1—esophageal cancer	0.000569	0.00149	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000566	0.00149	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL2—esophageal cancer	0.000559	0.00147	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—SST—esophageal cancer	0.000557	0.00146	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—GNG7—esophageal cancer	0.000557	0.00146	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KMT2D—esophageal cancer	0.000556	0.00146	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000545	0.00143	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—GHRL—esophageal cancer	0.000543	0.00142	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKAP13—esophageal cancer	0.000541	0.00142	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL2—esophageal cancer	0.00054	0.00142	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—WWOX—esophageal cancer	0.000536	0.00141	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000526	0.00138	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000525	0.00138	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—ANXA1—esophageal cancer	0.00052	0.00137	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—GNG7—esophageal cancer	0.000518	0.00136	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FKBP1A—esophageal cancer	0.00051	0.00134	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—SST—esophageal cancer	0.000506	0.00133	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000502	0.00132	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000501	0.00131	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—WIF1—esophageal cancer	0.000499	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000496	0.0013	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000495	0.0013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PDE4D—esophageal cancer	0.000494	0.0013	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—GHRL—esophageal cancer	0.000493	0.00129	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PFN1—esophageal cancer	0.000491	0.00129	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL2—esophageal cancer	0.00049	0.00129	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—SST—esophageal cancer	0.000488	0.00128	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—GHRL—esophageal cancer	0.000476	0.00125	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—GNG7—esophageal cancer	0.00047	0.00124	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000469	0.00123	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CSNK1A1—esophageal cancer	0.00046	0.00121	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000456	0.0012	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—ANXA1—esophageal cancer	0.000456	0.0012	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—WWOX—esophageal cancer	0.000453	0.00119	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—SST—esophageal cancer	0.000443	0.00116	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ELMO1—esophageal cancer	0.000441	0.00116	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—GHRL—esophageal cancer	0.000432	0.00113	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000431	0.00113	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKAP13—esophageal cancer	0.000431	0.00113	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PFN1—esophageal cancer	0.00043	0.00113	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000424	0.00111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—WIF1—esophageal cancer	0.000421	0.00111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.000414	0.00109	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—SST—esophageal cancer	0.000413	0.00108	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000402	0.00106	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000399	0.00105	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000398	0.00104	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PDE4D—esophageal cancer	0.000394	0.00104	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000393	0.00103	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000389	0.00102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ELMO1—esophageal cancer	0.000387	0.00102	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000385	0.00101	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKAP13—esophageal cancer	0.000378	0.000992	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000375	0.000985	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GNG7—esophageal cancer	0.000375	0.000985	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—SST—esophageal cancer	0.000375	0.000984	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00037	0.000971	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000365	0.000959	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PFN1—esophageal cancer	0.000364	0.000955	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—XIAP—esophageal cancer	0.000351	0.000923	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000349	0.000916	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PDE4D—esophageal cancer	0.000346	0.000908	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CTNNA1—esophageal cancer	0.000332	0.000872	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL2—esophageal cancer	0.00033	0.000867	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GNG7—esophageal cancer	0.000329	0.000863	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000327	0.000858	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000319	0.000839	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSME2—esophageal cancer	0.000309	0.00081	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSME1—esophageal cancer	0.000309	0.00081	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000308	0.000809	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000308	0.000809	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—XIAP—esophageal cancer	0.000308	0.000809	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ANXA1—esophageal cancer	0.000307	0.000806	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SST—esophageal cancer	0.000299	0.000784	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000295	0.000774	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000292	0.000767	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CTNNA1—esophageal cancer	0.000291	0.000765	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH3—esophageal cancer	0.000291	0.000764	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—GHRL—esophageal cancer	0.000291	0.000764	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL2—esophageal cancer	0.00029	0.000761	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FBXW7—esophageal cancer	0.000286	0.000752	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GNG7—esophageal cancer	0.000278	0.00073	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSME2—esophageal cancer	0.000271	0.00071	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSME1—esophageal cancer	0.000271	0.00071	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	0.000269	0.000707	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CA1—esophageal cancer	0.000262	0.000688	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000262	0.000688	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SST—esophageal cancer	0.000262	0.000688	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	0.000261	0.000686	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—XIAP—esophageal cancer	0.00026	0.000684	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	0.000255	0.00067	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—GHRL—esophageal cancer	0.000255	0.00067	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	0.000251	0.000659	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000246	0.000647	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000245	0.000643	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CA2—esophageal cancer	0.00024	0.000629	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	0.000232	0.000608	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	0.000229	0.000601	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSME2—esophageal cancer	0.000229	0.0006	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSME1—esophageal cancer	0.000229	0.0006	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000228	0.000598	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000223	0.000585	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000223	0.000585	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SST—esophageal cancer	0.000221	0.000581	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	0.000219	0.000576	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—GHRL—esophageal cancer	0.000216	0.000567	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000216	0.000567	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000212	0.000557	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	0.000203	0.000533	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000201	0.000529	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000201	0.000529	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000195	0.000513	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000194	0.000508	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	0.000192	0.000505	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000187	0.00049	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000182	0.000477	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	0.000179	0.000471	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000177	0.000465	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	0.000172	0.000451	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KDR—esophageal cancer	0.000172	0.000451	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000171	0.00045	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CA1—esophageal cancer	0.000171	0.00045	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000169	0.000443	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000169	0.000443	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	0.000162	0.000427	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000162	0.000425	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	0.000162	0.000424	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	0.000157	0.000413	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CA2—esophageal cancer	0.000157	0.000411	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000156	0.000409	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000154	0.000406	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KDR—esophageal cancer	0.00015	0.000395	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000147	0.000386	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	0.000147	0.000385	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000146	0.000383	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000146	0.000383	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	0.000144	0.000378	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	0.000142	0.000372	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000138	0.000361	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000138	0.000361	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	0.000133	0.000349	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOS3—esophageal cancer	0.000131	0.000345	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000131	0.000344	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000129	0.00034	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	0.000128	0.000337	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000128	0.000335	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KDR—esophageal cancer	0.000127	0.000334	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	0.000126	0.000332	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000125	0.000328	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	0.000123	0.000322	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000123	0.000322	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000123	0.000322	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000122	0.000321	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000121	0.000317	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000121	0.000317	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000121	0.000317	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	0.00012	0.000315	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000119	0.000312	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000116	0.000304	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOS3—esophageal cancer	0.000115	0.000302	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TPI1—esophageal cancer	0.00011	0.00029	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.00011	0.00029	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	0.00011	0.000288	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	0.000109	0.000285	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—esophageal cancer	0.000108	0.000285	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	0.000108	0.000283	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	0.000107	0.00028	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000106	0.000278	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	0.000105	0.000275	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.000104	0.000274	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000102	0.000268	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.000102	0.000268	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CRABP1—esophageal cancer	0.000101	0.000265	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EP300—esophageal cancer	9.98e-05	0.000262	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	9.81e-05	0.000258	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOS3—esophageal cancer	9.72e-05	0.000255	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GNG7—esophageal cancer	9.6e-05	0.000252	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—esophageal cancer	9.51e-05	0.00025	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	9.26e-05	0.000243	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	9.2e-05	0.000242	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	9.09e-05	0.000239	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDH2—esophageal cancer	9e-05	0.000236	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.95e-05	0.000235	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EP300—esophageal cancer	8.75e-05	0.00023	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—esophageal cancer	8.7e-05	0.000228	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.59e-05	0.000226	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.56e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—esophageal cancer	8.51e-05	0.000223	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.46e-05	0.000222	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—esophageal cancer	8.04e-05	0.000211	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO1—esophageal cancer	8.02e-05	0.000211	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.02e-05	0.000211	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSME1—esophageal cancer	7.9e-05	0.000208	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSME2—esophageal cancer	7.9e-05	0.000208	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	7.77e-05	0.000204	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—esophageal cancer	7.63e-05	0.0002	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—esophageal cancer	7.46e-05	0.000196	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EP300—esophageal cancer	7.4e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	7.38e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—esophageal cancer	7.14e-05	0.000188	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.82e-05	0.000179	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	6.47e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—esophageal cancer	6.45e-05	0.000169	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.41e-05	0.000168	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—esophageal cancer	6.3e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—esophageal cancer	6.26e-05	0.000164	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.85e-05	0.000154	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.74e-05	0.000151	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.62e-05	0.000147	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.47e-05	0.000144	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—esophageal cancer	5.29e-05	0.000139	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NOS3—esophageal cancer	5.14e-05	0.000135	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.7e-05	0.000123	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—EP300—esophageal cancer	3.91e-05	0.000103	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.75e-05	9.86e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NOS3—esophageal cancer	3.36e-05	8.83e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.07e-05	8.07e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.89e-05	7.6e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—EP300—esophageal cancer	2.56e-05	6.71e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.89e-05	4.97e-05	CbGpPWpGaD
